期刊文献+

甘肃省4个不同民族丙型肝炎病毒感染的基因型特征 被引量:4

下载PDF
导出
摘要 目的了解甘肃省4个民族丙型肝炎病毒(HCV)感染的分布特征及变异趋势。方法对甘肃省4个民族HCV感染的患者样本用实时荧光定量PCR进行病毒载量的确定,并对病毒载量大于103的样本用多重PCR进行HCV的基因分型。结果甘肃省汉族、回族、藏族及东乡族HCV感染主要以1b型为主,其次是2a型和2c型;在汉族、回族2个民族中检出3a型,藏族和东乡族中未检出;不同民族间1b型、2a型HCV感染比例比较差异无统计意义(P>0.05);在东乡族和藏族中发现了国内少见的1c型HCV感染。结论甘肃省4个民族HCV呈多基因型分布。
作者 杨伟国 徐辉
出处 《甘肃中医学院学报》 2013年第1期27-30,共4页 Journal of Gansu College of Traditional Chinese Medicine
  • 相关文献

参考文献11

  • 1Alberti A, Benvegnu L. Management of hepatitis C [ J ]. Hepatol,2003,38( Suppl 1 ) : 104-118.
  • 2刘妲妲,王全楚.输血后丙型肝炎患者的临床特点及自然病程[J].实用肝脏病杂志,2008,11(6):410-411. 被引量:22
  • 3丙型肝炎防治指南[J].中华流行病学杂志,2004,25(5):369-375. 被引量:65
  • 4Nguyen M H, Keeffe E B. Chronic hepatitis C : genotypes 4 to 9 [ J]. Olin Liver Dis ,2005,9 ( 3 ) :411-426.
  • 5Yuen M F, Lai C L. Response to combined interferon and ribavirin is better in patients infected with hepatitis C virus genotype 6 than genotype 1 in Hang Kang [ J ]. Intervirolo- gy,2006,49 (1-2) : 96-98.
  • 6Seeff L B, Hoofinagle J H. The national institutes of health consensus development conference management of hepatitis C2002 [ J]. Clin Liver Dis ,2003,7(1 ) :261-278.
  • 7Mdhutchison J G, Gordon S C, Schiff E R, et al. Interferonal- fa-2b alone or in combination with ribavirin as initial treat- ment for chronic hepatitis C. Hepatitis intervertional therapy group [ J ]. N Engl JM ed, 1998,339 ( 21 ) : 1485-1492.
  • 8Ramalho F. Hepatitis C virus infection and liver steatosis [ J ]. Antiviral Res,2003,60 ( 2 ) : 125-127.
  • 9Saito T, Ito T, Ishiko H, et al. Sepquence analysis of PePHD with in HCV E2 region and correlation with resistance of in- terferon therapy in Japanese patients infected with HCV genotypes 2a and 2b [ J ]. Am JG astroenerol, 2003,98 (6) : 1377-1383.
  • 10Diago M, H assanein T, Rode S J, et al. Optimized virologic response in hepatitis C virus genotype 4 with peginterfero- nalpha2a and ribavirin [ J ]. Ann Intern Med, 2004, 140 ( 1 ) :72-73.

二级参考文献20

  • 1李梦东,聂青和.丙型肝炎的诊断与治疗策略——美国肝病研究协会临床实践指南[J].实用肝脏病杂志,2004,7(4):250-256. 被引量:3
  • 2崇雨田,林潮双,赵志新,林国莉,李建国,高志良.输血后丙型肝炎患者的临床特点及自然病程[J].中华肝脏病杂志,2006,14(3):199-201. 被引量:11
  • 3王爱霞,盛瑞媛.输血后丙型肝炎的前瞻性研究[J].中华内科杂志,1996,35(10):659-662. 被引量:15
  • 4Alberti A, Benvegnu L. Management of hepatitis C. J Hepatol, 2003, 38(suppl 1)∶s1014-s1118.
  • 5Booth JCL, O'Grady J, Neuberger J. Clinical guidelines on the management of hepatitis C. Gut, 2001, 49(suppl 1)∶ s1-s21.
  • 6Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data. Gut, 2002, 51∶864-869.
  • 7Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review. Hepatology,2002,36(5 suppl 1)∶s135-s144.
  • 8Di Ciommo V, Russo P, Rava L, et al. Interferon alpha in the treatment of chronic hepatitis C in children: a meta-analysis. J Viral Hepat, 2003, 10∶210-214.
  • 9Fabrizi F, Dulai G, Dixit V, et al. Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther, 2003, 18∶1071-1081.
  • 10Kjaergard LL, Krogsgaard K, Gluud C. Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials. BMJ, 2001, 323∶1151-1155.

共引文献84

同被引文献107

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部